You are in the accessibility menu

Statistics

Total Visits

Views
The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1 114

Total Visits per Month

November 2024 December 2024 January 2025 February 2025 March 2025 April 2025 May 2025
The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1 1 1 8 8 3 6 1

File Downloads

Views

Top Country Views

Views
United States 57
Germany 23
Brazil 8
China 8
Russia 7
Ukraine 5
Japan 3
France 1
Kazakhstan 1
Vietnam 1

Top City Views

Views
Ashburn 17
San Mateo 10
Fairfield 7
Cambridge 6
Jacksonville 5
Seattle 3
Tokyo 3
Korolëv 2
Nanjing 2
Yang 2